Metformin and berberine, two versatile drugs in treatment of common metabolic diseases

Metformin has been used as a glucose lowering drug for several centuries and is now a first-line drug for type 2 diabetes mellitus (T2DM). Since the discovery that it activates AMP-activated protein kinase (AMPK) and reduces risk of cancer, metformin has drawn great attentions. Another drug, berberi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haoran, Zhu, Chen, Ying, Ying, Luo, Lingyu, Huang, Deqiang, Luo, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839379/
https://www.ncbi.nlm.nih.gov/pubmed/29515798
http://dx.doi.org/10.18632/oncotarget.20807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839379/
https://www.ncbi.nlm.nih.gov/pubmed/29515798
http://dx.doi.org/10.18632/oncotarget.20807

Ejemplares similares